Home › Premarket Biotech Digest: Anavex's Results, Gilead's HCV Sales, Sanofi's Strategic Roadmap
 

Keywords :   


Premarket Biotech Digest: Anavex's Results, Gilead's HCV Sales, Sanofi's Strategic Roadmap

2015-11-09 20:25:41| Biotech - Topix.net

Click this link to find out how much you can save.) Anavex is down 8% premarket after a large drop on Friday, just before the Nov 7 results from 32 patients in its phase 2a trial part A. I plan to do a thorough study of this tomorrow, but meanwhile, here are a few quick thoughts for those who are undecided about whether to sell or hold. . First, if you want to follow someone's advice, take it in its entirety, don't do it piecemeal.

Tags: results sales strategic digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
More »